Alphabet

EZOLONG®

Indication: 

Adults: ∙ Antisecretory therapy when it is impossible to use the oral route of administration: - gastroesophageal reflux disease in patients with esophagitis and / or severe reflux symptoms; - treatment of gastric ulcers associated with the treatment of nonsteroidal anti-inflammatory drugs (NSAIDs); - prevention of gastric and duodenal ulcers associated with NSAID therapy in at-risk patients. ∙ Short-term maintenance of hemostasis and prevention of recurrent bleeding in patients after endoscopic treatment of acute bleeding due to the ulcer of stomach or duodenum. Children from 1 to 18 years: ∙ Antisecretory therapy when it is impossible to use the oral route of administration: - gastroesophageal reflux disease (GERD) in patients with erosive reflux esophagitis and / or severe reflux symptoms.  

Ezolong®-20/ Ezolong®-40

Indication: 

The drug is used to treat gastroesophageal reflux disease; Erosive reflux esophagitis; For long-term maintenance therapy with treated esophagitis to prevent relapse; For the healing of duodenal ulcer, associated with Helicobacter pylori; Caused by therapy with NSAIDs.